Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1605)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3722)
  2. Department of Medicine (3691)
  3. Hematologic Malignancies, Division of (3687)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (389)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (105)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (325)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3722)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • HSC commitment-associated epigenetic signature is prognostic in acute myeloid leukemia
    Journal Article

    Bartholdy, B.; Christopeit, M.; Will, B.; Mo, Y.; Barreyro, L.; Yu, Y.; Bhagat, T. D.; Okoye-Okafor, U. C.; Todorova, T. I.; Greally, J. M.; more...
    Journal of Clinical Investigation (2014)

    Fulltext@MSK | Save
  • Erythropoietin promotes breast tumorigenesis through tumor-initiating cell self-renewal
    Journal Article

    Zhou, B.; Damrauer, J. S.; Bailey, S. T.; Hadzic, T.; Jeong, Y.; Clark, K.; Fan, C.; Murphy, L.; Lee, C. Y.; Troester, M. A.; more...
    Journal of Clinical Investigation (2014)

    Fulltext@MSK | Save
  • Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis
    Journal Article

    Madzo, J.; Liu, H.; Rodriguez, A.; Vasanthakumar, A.; Sundaravel, S.; Caces, D.; Looney, T.; Zhang, L.; Lepore, J.; Macrae, T.; more...
    Cell Reports (2014)

    Fulltext@MSK | Save
  • Leukaemogenesis induced by an activating β-catenin mutation in osteoblasts
    Journal Article

    Kode, A.; Manavalan, J. S.; Mosialou, I.; Bhagat, G.; Rathinam, C. V.; Luo, N.; Khiabanian, H.; Lee, A.; Murty, V. V.; Friedman, R.; more...
    Nature (2014)

    Fulltext@MSK | Save
  • Point mutation E1099K in MMSET/NSD2 enhances its methyltranferase activity and leads to altered global chromatin methylation in lymphoid malignancies
    Journal Article

    Oyer, J. A.; Huang, X.; Zheng, Y.; Shim, J.; Ezponda, T.; Carpenter, Z.; Allegretta, M.; Okot-Kotber, C. I.; Patel, J. P.; Melnick, A.; more...
    Leukemia (2014)

    Fulltext@MSK | Save
  • Imatinib 800 mg daily induces deeper molecular responses than imatinib 400 mg daily: Results of SWOG S0325, an intergroup randomized PHASE II trial in newly diagnosed chronic phase chronic myeloid leukaemia
    Journal Article

    Deininger, M. W.; Kopecky, K. J.; Radich, J. P.; Kamel-Reid, S.; Stock, W.; Paietta, E.; Emanuel, P. D.; Tallman, M.; Wadleigh, M.; Larson, R. A.; more...
    British Journal of Haematology (2014)

    Fulltext@MSK | Save
  • Application of the French prognostic score (FPS) to assess overall survival (OS) in a US-based cohort of patients (pts) treated with azacitidine (Aza)
    Meeting Abstract

    Zeidan, A.; Sun, Z.; Prebet, T.; Greenberg, P.; Juckett, M.; Smith, M. R.; Paietta, E.; Gabrilove, J. L.; Erba, H. P.; Gore, S.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A phase II study of mocetinostat, an oral isotype-selective histone deacetylase (HDAC) inhibitor, in combination with 5-azacitidine in patients with myelodysplastic syndrome (MDS)
    Meeting Abstract

    Luger, S. M.; O'Connell, C. L.; Klimek, V.; Cooper, M. A.; Besa, E. C.; Rossetti, J. M.; Reid, G. K.; Humphrey, R.; Martell, R. E.; Garcia-Manero, G.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Multivariate analysis of factors affecting overall survival, event free survival, and 60-day mortality among AML patients treated with CPX-351 or intensive chemotherapy
    Meeting Abstract

    Feldman, E. J.; Lancet, J. E.; Kolitz, J. E.; Hogge, D.; Tallman, M. S.; Goldberg, S. L.; Kovacsovics, T.; Louie, A. C.; Cortes, J. E.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Therapeutic superiority of a TCR-like antibody to an intracellular WT1 oncogene peptide compared with the tyrosine kinase inhibitor imatinib in a mouse model of Philadelphia chromosome positive (Ph+) ALL
    Meeting Abstract

    Dubrovsky, L.; Brea, E. J.; Veomett, N. J.; Dao, T.; Yan, S.; Liu, C.; Scheinberg, D. A.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save